CN115896240B - Method for constructing mitochondrial genome sequencing library - Google Patents
Method for constructing mitochondrial genome sequencing library Download PDFInfo
- Publication number
- CN115896240B CN115896240B CN202211367152.6A CN202211367152A CN115896240B CN 115896240 B CN115896240 B CN 115896240B CN 202211367152 A CN202211367152 A CN 202211367152A CN 115896240 B CN115896240 B CN 115896240B
- Authority
- CN
- China
- Prior art keywords
- tube
- mtdna
- mitochondrial genome
- mitochondrial
- magnetic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title claims abstract description 50
- 230000002438 mitochondrial effect Effects 0.000 title claims abstract description 44
- 238000012268 genome sequencing Methods 0.000 title claims abstract description 18
- 239000012634 fragment Substances 0.000 claims abstract description 22
- 108020005196 Mitochondrial DNA Proteins 0.000 claims abstract description 21
- 238000000926 separation method Methods 0.000 claims abstract description 13
- 108060002716 Exonuclease Proteins 0.000 claims abstract description 7
- 102000013165 exonuclease Human genes 0.000 claims abstract description 7
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 6
- 108010012306 Tn5 transposase Proteins 0.000 claims abstract description 5
- 239000011324 bead Substances 0.000 claims description 31
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 24
- 239000006228 supernatant Substances 0.000 claims description 16
- 238000012163 sequencing technique Methods 0.000 claims description 12
- 108020004414 DNA Proteins 0.000 claims description 10
- 210000004027 cell Anatomy 0.000 claims description 10
- 238000000746 purification Methods 0.000 claims description 10
- 102000004190 Enzymes Human genes 0.000 claims description 7
- 108090000790 Enzymes Proteins 0.000 claims description 7
- 239000000047 product Substances 0.000 claims description 7
- 238000012350 deep sequencing Methods 0.000 claims description 6
- 238000001085 differential centrifugation Methods 0.000 claims description 6
- 238000013467 fragmentation Methods 0.000 claims description 6
- 238000006062 fragmentation reaction Methods 0.000 claims description 6
- 210000004698 lymphocyte Anatomy 0.000 claims description 5
- 238000000246 agarose gel electrophoresis Methods 0.000 claims description 4
- 238000000137 annealing Methods 0.000 claims description 4
- 210000004369 blood Anatomy 0.000 claims description 4
- 239000008280 blood Substances 0.000 claims description 4
- 238000005119 centrifugation Methods 0.000 claims description 4
- 238000004925 denaturation Methods 0.000 claims description 4
- 230000036425 denaturation Effects 0.000 claims description 4
- 210000003819 peripheral blood mononuclear cell Anatomy 0.000 claims description 4
- 238000012257 pre-denaturation Methods 0.000 claims description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 3
- 239000007924 injection Substances 0.000 claims description 3
- 238000002347 injection Methods 0.000 claims description 3
- 239000002184 metal Substances 0.000 claims description 3
- 239000002096 quantum dot Substances 0.000 claims description 3
- 238000005406 washing Methods 0.000 claims description 3
- 238000007399 DNA isolation Methods 0.000 claims description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 2
- 239000000499 gel Substances 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 210000001616 monocyte Anatomy 0.000 claims description 2
- 210000005087 mononuclear cell Anatomy 0.000 claims description 2
- 210000005259 peripheral blood Anatomy 0.000 claims description 2
- 239000011886 peripheral blood Substances 0.000 claims description 2
- 239000002244 precipitate Substances 0.000 claims description 2
- 210000000130 stem cell Anatomy 0.000 claims description 2
- 238000012360 testing method Methods 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims 6
- 230000010355 oscillation Effects 0.000 claims 3
- 239000003146 anticoagulant agent Substances 0.000 claims 1
- 229940127219 anticoagulant drug Drugs 0.000 claims 1
- 238000010009 beating Methods 0.000 claims 1
- 238000007664 blowing Methods 0.000 claims 1
- 239000003480 eluent Substances 0.000 claims 1
- 239000002504 physiological saline solution Substances 0.000 claims 1
- 238000012408 PCR amplification Methods 0.000 abstract description 3
- 239000000523 sample Substances 0.000 description 17
- 238000010276 construction Methods 0.000 description 12
- 210000003470 mitochondria Anatomy 0.000 description 8
- 239000000203 mixture Substances 0.000 description 7
- 238000012165 high-throughput sequencing Methods 0.000 description 5
- 230000035772 mutation Effects 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 4
- 238000012546 transfer Methods 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- 108091026890 Coding region Proteins 0.000 description 2
- 108010046914 Exodeoxyribonuclease V Proteins 0.000 description 2
- 102000019236 Exonuclease V Human genes 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000012175 pyrosequencing Methods 0.000 description 2
- 238000007480 sanger sequencing Methods 0.000 description 2
- 238000012070 whole genome sequencing analysis Methods 0.000 description 2
- 108020004463 18S ribosomal RNA Proteins 0.000 description 1
- 108091093088 Amplicon Proteins 0.000 description 1
- 108020004638 Circular DNA Proteins 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 230000005971 DNA damage repair Effects 0.000 description 1
- 102000006947 Histones Human genes 0.000 description 1
- 108010033040 Histones Proteins 0.000 description 1
- 101001121408 Homo sapiens L-amino-acid oxidase Proteins 0.000 description 1
- 102100026388 L-amino-acid oxidase Human genes 0.000 description 1
- 206010052641 Mitochondrial DNA mutation Diseases 0.000 description 1
- 101710163270 Nuclease Proteins 0.000 description 1
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 1
- 101100012902 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) FIG2 gene Proteins 0.000 description 1
- 101100233916 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) KAR5 gene Proteins 0.000 description 1
- 108020004566 Transfer RNA Proteins 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 210000003855 cell nucleus Anatomy 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 230000001086 cytosolic effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 208000012268 mitochondrial disease Diseases 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 102000026415 nucleotide binding proteins Human genes 0.000 description 1
- 108091014756 nucleotide binding proteins Proteins 0.000 description 1
- 239000002751 oligonucleotide probe Substances 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
技术领域Technical Field
本发明属于生物领域,涉及一种构建线粒体基因组测序文库的方法。The invention belongs to the biological field and relates to a method for constructing a mitochondrial genome sequencing library.
背景技术Background technique
线粒体是细胞中提供能量的重要细胞器,在生物体能量转换和新陈代谢中处于核心地位。线粒体中携带一套独立于核基因组的线粒体基因组(即mtDNA)。人线粒体基因组是一个全长为16569bp的双链闭合环状DNA分子,分为编码区以及非编码的D-loop区,编码区能够编码13种多肽链、22种tRNA和2种rRNA。mtDNA分子上无核苷酸结合蛋白,缺少组蛋白的保护,基因与基因之间少有间隔,并且线粒体内无DNA损伤修复系统,因此mtDNA易于突变且突变难以修复并遗传到子代细胞。此外,由于每个细胞中存在成百上千个mtDNA,经常存在突变型mtDNA与野生型mtDNA共存的现象,被称为异质性。线粒体DNA的这些特点为全线粒体基因组测序带来很大的困难。Mitochondria are important organelles that provide energy in cells and play a core role in energy conversion and metabolism of organisms. Mitochondria carry a mitochondrial genome (mtDNA) that is independent of the nuclear genome. The human mitochondrial genome is a double-stranded closed circular DNA molecule with a total length of 16569bp, which is divided into a coding region and a non-coding D-loop region. The coding region can encode 13 polypeptide chains, 22 tRNAs and 2 rRNAs. There are no nucleotide binding proteins on the mtDNA molecule, lack the protection of histones, there are few intervals between genes, and there is no DNA damage repair system in mitochondria. Therefore, mtDNA is prone to mutation and mutations are difficult to repair and inherit to daughter cells. In addition, since there are hundreds or thousands of mtDNAs in each cell, there is often a phenomenon of coexistence of mutant mtDNA and wild-type mtDNA, which is called heteroplasmy. These characteristics of mitochondrial DNA bring great difficulties to the sequencing of the whole mitochondrial genome.
现在可用于线粒体基因组测序的方法有以下几种:There are several methods currently available for mitochondrial genome sequencing:
一、一代Sanger测序可以检出异质性大于10%以上的突变位点,是单个纯合位点检测的金标准。但是一代Sanger测序不能用于全线粒体基因组测序,并且基于该技术的低灵敏度,通常不能准确地检测到低于10%的异质度。First-generation Sanger sequencing can detect mutation sites with heteroplasmy greater than 10%, and is the gold standard for detecting single homozygous sites. However, first-generation Sanger sequencing cannot be used for whole mitochondrial genome sequencing, and based on the low sensitivity of this technology, it usually cannot accurately detect heteroplasmy below 10%.
二、焦磷酸测序使用边合成边测序技术,首先获得300-800bp的目的DNA片段,然后在两端加上衔接子组成目的DNA的样品文库,之后将目的DNA片段固定到磁珠上,形成油包水结构进行独立扩增,从而实现所有目的DNA片段的平行PCR扩增及高通量测序,适用于特定位点的定量检测。但由于样本损耗量大,且一次实验无法检测整个线粒体基因组,相对成本较高,因此焦磷酸测序较难用于全线粒体基因组的深度测序。Second, pyrosequencing uses sequencing-by-synthesis technology to first obtain a 300-800bp target DNA fragment, then add adapters at both ends to form a sample library of the target DNA, and then fix the target DNA fragment to the magnetic beads to form an oil-in-water structure for independent amplification, thereby achieving parallel PCR amplification and high-throughput sequencing of all target DNA fragments, which is suitable for quantitative detection of specific sites. However, due to the large amount of sample loss and the inability to detect the entire mitochondrial genome in one experiment, the relatively high cost makes pyrosequencing difficult to use for deep sequencing of the entire mitochondrial genome.
三、探针捕获法通过制备生物素标记的与mtDNA互补的寡核苷酸探针,然后与mtDNA杂交,捕获、富集目的片段,再进行高通量测序[He Y,Wu J,Dressman DC,Iacobuzio-Donahue C,Markowitz SD,Velculescu VE,Diaz LA Jr,Kinzler KW,Vogelstein B,Papadopoulos N.Heteroplasmic mitochondrial DNA mutations in normal and tumourcells.Nature.2010Mar 25;464(7288):610-4.doi:10.1038/nature08802.Epub 2010Mar3.PMID:20200521;PMCID:PMC3176451.]。虽然该方法可以用于全线粒体基因组测序,准确度高,但探针捕获法耗时长,成本高,且无法有效避免细胞核基因组中同源序列干扰。3. Probe capture method: Prepare biotin-labeled oligonucleotide probes complementary to mtDNA, then hybridize with mtDNA to capture and enrich the target fragments, and then perform high-throughput sequencing [He Y, Wu J, Dressman DC, Iacobuzio-Donahue C, Markowitz SD, Velculescu VE, Diaz LA Jr, Kinzler KW, Vogelstein B, Papadopoulos N. Heteroplasmic mitochondrial DNA mutations in normal and tumour cells. Nature. 2010 Mar 25; 464(7288): 610-4. doi: 10.1038/nature08802. Epub 2010 Mar 3. PMID: 20200521; PMCID: PMC3176451.]. Although this method can be used for whole mitochondrial genome sequencing with high accuracy, the probe capture method is time-consuming, costly, and cannot effectively avoid interference from homologous sequences in the nuclear genome.
四、长片段PCR法一般将线粒体DNA分成两段,通过两对引物特异性扩增mtDNA,随后进行高通量测序,可以用于全线粒体基因组测序。但是该方法仍存在一定局限性,包括:建库耗时较长,效率较低;且由于长片段PCR不具备很好的校正功能,易掺入错误碱基并易产生偏好性,可能影响最终的测序结果。但即便如此,该方法仍然是目前全线粒体基因组测序最常用的方法[Emonet S,Grard G,Brisbarre N,Moureau G,Temmam S,Charrel R,deLamballerie X.LoPPS:a long PCR product sequencing method for rapidcharacterisation of long amplicons.Biochem Biophys Res Commun.2006Jun 16;344(4):1080-5.doi:10.1016/j.bbrc.2006.04.015.Epub 2006Apr 19.PMID:16643852.]。Fourth, the long-fragment PCR method generally divides mitochondrial DNA into two segments, and uses two pairs of primers to specifically amplify mtDNA, followed by high-throughput sequencing, which can be used for whole mitochondrial genome sequencing. However, this method still has certain limitations, including: library construction is time-consuming and inefficient; and because long-fragment PCR does not have a good correction function, it is easy to incorporate incorrect bases and produce bias, which may affect the final sequencing results. But even so, this method is still the most commonly used method for whole mitochondrial genome sequencing [Emonet S, Grard G, Brisbarre N, Moureau G, Temmam S, Charrel R, deLamballerie X. LoPPS: a long PCR product sequencing method for rapid characterization of long amplicons. Biochem Biophys Res Commun. 2006 Jun 16; 344(4): 1080-5. doi: 10.1016/j.bbrc.2006.04.015. Epub 2006 Apr 19. PMID: 16643852.].
五、全基因组测序在获得细胞核基因组序列的同时也可以获得线粒体基因组的序列信息,但是该方法成本过高,且同探针捕获法一样,全基因组测序无法避免细胞核基因组同源序列的干扰[Schon KR,Ratnaike T,van den Ameele J,Horvath R,ChinneryPF.Mitochondrial Diseases:A Diagnostic Revolution.Trends Genet.2020Sep;36(9):702-717.doi:10.1016/j.tig.2020.06.009.Epub 2020Jul 13.PMID:32674947.]。5. Whole genome sequencing can obtain the sequence information of the mitochondrial genome while obtaining the nuclear genome sequence, but this method is too expensive, and like the probe capture method, whole genome sequencing cannot avoid the interference of homologous sequences of the nuclear genome [Schon KR, Ratnaike T, van den Ameele J, Horvath R, Chinnery PF. Mitochondrial Diseases: A Diagnostic Revolution. Trends Genet. 2020 Sep; 36 (9): 702-717. doi: 10.1016/j.tig.2020.06.009. Epub 2020 Jul 13. PMID: 32674947.].
发明内容Summary of the invention
针对目前方法上存在的这些操作或成本上的局限,本发明意在提供一种基于线粒体分离纯化技术的建库方法和高通量测序方法,可实现简单、经济、快速的线粒体基因组深度测序。In view of the operational or cost limitations of current methods, the present invention intends to provide a library construction method and a high-throughput sequencing method based on mitochondrial separation and purification technology, which can achieve simple, economical and rapid deep sequencing of the mitochondrial genome.
一种构建线粒体基因组测序文库的方法,包括通过核质分离获得纯化的mtDNA,加入核酸外切酶Exo V去除核基因,加入Tn5转座酶将mtDNA片段化从而构建线粒体基因组测序文库。A method for constructing a mitochondrial genome sequencing library comprises obtaining purified mtDNA by nuclear-cytoplasmic separation, adding exonuclease Exo V to remove nuclear genes, and adding Tn5 transposase to fragment the mtDNA to construct a mitochondrial genome sequencing library.
作为本发明的一种优选,所述的方法,其特征在于包括以下步骤:As a preferred embodiment of the present invention, the method is characterized in that it comprises the following steps:
I:使用淋巴细胞分离液,通过差速离心,分离外周血单个核细胞(PBMC);I: Use lymphocyte separation medium to separate peripheral blood mononuclear cells (PBMC) by differential centrifugation;
II:线粒体DNA分离纯化:II: Mitochondrial DNA isolation and purification:
a.通过核质分离,尽可能去除细胞核,获得纯化后的线粒体;a. Through nuclear-cytoplasmic separation, remove the cell nucleus as much as possible to obtain purified mitochondria;
b.加入核酸外切酶Exo V去除少量残留的核基因组DNA;b. Add exonuclease Exo V to remove a small amount of residual nuclear genomic DNA;
III:Tn5酶片段化建库:III: Tn5 enzyme fragmentation library construction:
a.向纯化的线粒体中加入Tn5酶使环状mtDNA片段化;a. Add Tn5 enzyme to purified mitochondria to fragment circular mtDNA;
b.双轮磁珠分选;b. Double-wheel magnetic bead sorting;
c.吸取磁珠分选的洗脱液进行Qubit浓度测定,然后混样。c. Pipette the eluate from the magnetic bead separation for Qubit concentration determination, and then mix the samples.
作为本发明的进一步优选,所述的核质分离,获取mtDNA的具体步骤为:As a further preferred embodiment of the present invention, the specific steps of separating nucleocytoplasm and obtaining mtDNA are as follows:
(1)向差速离心后获得的细胞沉淀中加入RSB Buffer;(1) Add RSB Buffer to the cell pellet obtained after differential centrifugation;
(2)吹打若干次,转移至离心管内;(2) Pipet and swirl several times and transfer to a centrifuge tube;
(3)4℃度离心;(3) Centrifugation at 4°C;
(4)立即吸取上清。(4) Immediately aspirate the supernatant.
作为本发明的进一步优选,所述的加入核酸外切酶Exo V去除残留核基因组DNA,按照下表加入各组分:As a further preferred embodiment of the present invention, the exonuclease Exo V is added to remove the residual nuclear genomic DNA, and each component is added according to the following table:
37℃反应25-35分钟,去除残留的核基因组;然后65-70℃反应25-35分钟。Incubate at 37°C for 25-35 minutes to remove residual nuclear genome; then incubate at 65-70°C for 25-35 minutes.
作为本发明的进一步优选,所述的向纯化的线粒体中加入Tn5酶使mtDNA片段化包括以下步骤:As a further preferred embodiment of the present invention, the step of adding Tn5 enzyme to the purified mitochondria to fragment the mtDNA comprises the following steps:
(1)向纯化的线粒体中加入2xTD和Tn5,混匀;(1) Add 2xTD and Tn5 to the purified mitochondria and mix well;
(2)37℃金属浴,震荡20-40min;(2) 37°C metal bath, shake for 20-40 min;
(3)使用Zymo D4014试剂盒进行纯化;(3) Purification using the Zymo D4014 kit;
(4)PCR加接头引物。(4) PCR with adapter primers.
作为本发明的进一步优选,所述的PCR程序为:As a further preference of the present invention, the PCR procedure is:
98℃预变性30秒;98℃变性10秒,63℃退火30秒,72℃延伸1分钟,循环16-18次;4℃保持;Pre-denaturation at 98°C for 30 seconds; denaturation at 98°C for 10 seconds, annealing at 63°C for 30 seconds, extension at 72°C for 1 minute, cycle 16-18 times; maintain at 4°C;
作为本发明的进一步优选,所述的双轮磁珠分选包括以下步骤:As a further preferred embodiment of the present invention, the double-wheel magnetic bead sorting comprises the following steps:
1):吸取0.5×磁珠至PCR产物中,涡旋振荡混匀,瞬时离心后室温静置;1) Pipette 0.5× magnetic beads into the PCR product, vortex to mix, centrifuge briefly and let stand at room temperature;
2):将EP管置于磁力架上,静置至磁珠完全吸附;2): Place the EP tube on the magnetic rack and let it stand until the magnetic beads are completely adsorbed;
3):保持EP管置于磁力架上,小心吸取上清至新的EP管,避免接触到磁珠;3): Keep the EP tube on the magnetic stand and carefully pipette the supernatant into a new EP tube to avoid contact with the magnetic beads;
4):加入0.3×磁珠,涡旋振荡混匀,瞬时离心后室温静置;4): Add 0.3× magnetic beads, vortex to mix, centrifuge briefly, and let stand at room temperature;
5):将EP管置于磁力架上,静置至磁珠完全吸附;5): Place the EP tube on the magnetic rack and let it stand until the magnetic beads are completely adsorbed;
6):保持EP管置于磁力架上,小心吸弃上清;6) Keep the EP tube on the magnetic rack and carefully discard the supernatant;
7):向EP管中加入新鲜配置的80%乙醇,静置3-5min,待悬起的磁珠完全吸附后吸弃乙醇;7) Add freshly prepared 80% ethanol to the EP tube and let it stand for 3-5 minutes. After the suspended magnetic beads are completely adsorbed, discard the ethanol;
8):80%乙醇重复洗涤一次,然后吸净;8): Repeat washing once with 80% ethanol, then aspirate clean;
9):保持EP管置于磁力架上,静置至乙醇挥发干净;9): Keep the EP tube on the magnetic rack and let it stand until the ethanol evaporates completely;
10):向EP管中加入H20,涡旋振荡混匀,室温静置;10): Add H 2 0 to the EP tube, vortex to mix, and let stand at room temperature;
11):将EP管置于磁力架上,静置至磁珠完全吸附;11): Place the EP tube on the magnetic rack and let it stand until the magnetic beads are completely adsorbed;
12):吸取洗脱液至新的EP管中,弃去磁珠。12): Pipette the eluate into a new EP tube and discard the magnetic beads.
一种全线粒体基因组深度测序方法,通过本发明所述的方法创建线粒体基因组测序文库,再利用Illumina平台双端测序获得全线粒体基因组深度测序结果。A method for deep sequencing of a whole mitochondrial genome, which uses the method described in the present invention to create a mitochondrial genome sequencing library, and then uses Illumina platform double-end sequencing to obtain the deep sequencing results of the whole mitochondrial genome.
有益效果:Beneficial effects:
与现有的方法相比,本技术创新性地实现了一种基于线粒体纯化以及高通量测序的线粒体基因组测序的建库方法。通过核质分离提纯线粒体DNA,可以获得高纯度不含核基因组DNA的mtDNA(附图1),并且在Tn5转座酶将其片段化之前无需对初始mtDNA进行PCR扩增,可以避免PCR引起的序列偏好性,引入额外突变的问题。另外,本建库方法耗时短:线粒体分离纯化需要1.5h、核酸外切酶去除核基因1h、Tn5片段化1h、PCR加接头引物及琼脂糖凝胶电泳1h、磁珠分选1h,因此6h之内即可完成建库,优于基于长片段PCR的建库方法,提高了线粒体基因组测序文库构建的效率。Compared with existing methods, this technology innovatively implements a library construction method for mitochondrial genome sequencing based on mitochondrial purification and high-throughput sequencing. By separating and purifying mitochondrial DNA by nucleoplasm, high-purity mtDNA that does not contain nuclear genome DNA can be obtained (Figure 1), and there is no need to perform PCR amplification on the initial mtDNA before the Tn5 transposase fragments it, which can avoid the sequence preference caused by PCR and the problem of introducing additional mutations. In addition, this library construction method is time-saving: mitochondrial separation and purification requires 1.5 hours, nuclease exonuclease removal of nuclear genes requires 1 hour, Tn5 fragmentation requires 1 hour, PCR plus adapter primers and agarose gel electrophoresis requires 1 hour, and magnetic bead sorting requires 1 hour, so the library construction can be completed within 6 hours, which is better than the library construction method based on long-fragment PCR and improves the efficiency of mitochondrial genome sequencing library construction.
附图说明BRIEF DESCRIPTION OF THE DRAWINGS
图1是6个样本的线粒体提纯效率图:S1-6分别来自不同血样,每个样本4条泳道分别为针对核基因组18S、28S以及针对线粒体基因组m.8363、m.13513位点设计的引物:S1-S6均仅扩增出线粒体基因组目的条带,说明该方法有效地分离纯化了线粒体DNA且不含核基因组DNA。Figure 1 is a graph of the mitochondrial purification efficiency of six samples: S1-6 are from different blood samples, and the four lanes of each sample are primers designed for the nuclear genome 18S, 28S and the mitochondrial genome m.8363, m.13513 sites: S1-S6 only amplified the mitochondrial genome target bands, indicating that this method effectively separates and purifies mitochondrial DNA and does not contain nuclear genome DNA.
图2为A、B、C、D4例不同样本使用本发明方法通过分离纯化线粒体DNA,Tn5酶片段化建库后得到的产物的凝胶电泳图,大小在185-1000bp之间。FIG2 is a gel electrophoresis diagram of the products obtained from mitochondrial DNA of four different samples A, B, C, and D using the method of the present invention, after Tn5 enzyme fragmentation and library construction, with a size ranging from 185 to 1000 bp.
图3是样本1经本发明方法和长片段PCR方法所测得的测序文库覆盖度图。FIG3 is a diagram showing the coverage of the sequencing library of sample 1 measured by the method of the present invention and the long-fragment PCR method.
具体实施方式Detailed ways
实施例1Example 1
1、差速离心,分离外周血PBMC:1. Differential centrifugation to separate peripheral blood PBMC:
(1)取新鲜EDTA抗凝血1ml,与注射用生理盐水1:1混匀,温柔吹打;(1) Take 1 ml of fresh EDTA anticoagulated blood and mix it with normal saline for injection in a ratio of 1:1, then gently pipette and vortex;
(2)将稀释血液小心加至2ml淋巴细胞分离液(STEMCELL)的液面上;(2) Carefully add the diluted blood to the surface of 2 ml of lymphocyte separation medium (STEMCELL);
(3)400g,离心20分钟;(3) Centrifugation at 400 g for 20 min;
(4)此时离心管中由上至下细胞分四层:第一层为血浆层,第二层为环状乳白色细胞层(单个核细胞,包括淋巴细胞和单核细胞),第三层为透明分离液层,第四层为红细胞层。收集第二层细胞放入含注射用生理盐水5-10毫升的试管中,充分混匀;(4) At this time, the cells in the centrifuge tube are divided into four layers from top to bottom: the first layer is the plasma layer, the second layer is the ring-shaped milky white cell layer (mononuclear cells, including lymphocytes and monocytes), the third layer is the transparent separation liquid layer, and the fourth layer is the red blood cell layer. Collect the second layer of cells and put them into a test tube containing 5-10 ml of injection saline and mix them thoroughly;
(5)250g,离心10分钟,弃上清;(5) Centrifuge at 250 g for 10 min and discard the supernatant;
(6)重复步骤5,吸净上清;(6) Repeat step 5 and aspirate the supernatant;
2、线粒体DNA分离纯化:2. Mitochondrial DNA separation and purification:
2.1:核质分离,获取mtDNA2.1: Nuclear and cytoplasmic separation to obtain mtDNA
(1)向差速离心后获得的沉淀中加入15uL RSB Buffer;(1) Add 15uL RSB Buffer to the precipitate obtained after differential centrifugation;
(2)吹打五次,转移至1.5ML离心管内;(2) Pipette five times and transfer to a 1.5 mL centrifuge tube;
(3)4度离心,10000g,5min;(3) Centrifugation at 4°C, 10,000 g, 5 min;
(4)立即吸取上清至新的1.5ML离心管;(4) Immediately transfer the supernatant to a new 1.5 mL centrifuge tube;
2.2、核酸外切酶Exo V去除核基因:(NEB#M0345L)2.2. Exonuclease Exo V to remove nuclear genes: (NEB#M0345L)
37℃反应25-35分钟,去除残留的核基因组;然后65-70℃反应25-35分钟。Incubate at 37°C for 25-35 minutes to remove residual nuclear genome; then incubate at 65-70°C for 25-35 minutes.
2.3、使用Zymo D4014试剂盒纯化产物,9uL H20洗脱;2.3. Purify the product using the Zymo D4014 kit and elute with 9uL H20;
2.4、PCR跑胶验证,使用Vazyme P112-01试剂盒:2.4. PCR gel verification, using Vazyme P112-01 kit:
18S rRNA:For:CACGGACAGGATTGACAGATTGAT(SEQ ID NO.1);18S rRNA: For: CACGGACAGGATTGACAGATTGAT (SEQ ID NO. 1);
Rev:GCCAGAGTCTCGTTCGTTATCG(SEQ ID NO.2);Rev:GCCAGAGTCTCGTTCGTTATCG (SEQ ID NO. 2);
28S rRNA:For:TGGAATGCGAGTGCCTAGTG(SEQ ID NO.3);28S rRNA: For: TGGAATGCGAGTGCCTAGTG (SEQ ID NO. 3);
Rev:ACCGTCCTGCTGTCTATATCAAC(SEQ ID NO.4);Rev: ACCGTCCTGCTGTCTATATCAAC (SEQ ID NO. 4);
13513-For:ACCATTGGCAGCCTAGCATT(SEQ ID NO.5);13513-For: ACCATTGGCAGCCTAGCATT (SEQ ID NO. 5);
13513-Rev:GTTGTTTGGAAGGGGGATGC(SEQ ID NO.6);13513-Rev: GTTGTTTGGAAGGGGGATGC (SEQ ID NO. 6);
8363-For:GCAAACCACAGTTTCATGCCCA(SEQ ID NO.7);8363-For: GCAACCAGTTTCATGCCCA (SEQ ID NO. 7);
8363-Rev:TTATGGTGGGCCATACGGTAGTA(SEQ ID NO.8);8363-Rev: TTATGGTGGGCCATACGGTAGTA (SEQ ID NO. 8);
反应体系为:98℃预变性30秒;98℃变性10秒,63℃退火30秒,72℃延伸1分钟,循环35次;4℃保持;The reaction system was as follows: pre-denaturation at 98°C for 30 seconds; denaturation at 98°C for 10 seconds, annealing at 63°C for 30 seconds, extension at 72°C for 1 minute, 35 cycles; hold at 4°C;
2.5、2%琼脂糖凝脂电泳跑胶,180V、180mA、100W,30分钟,得到结果如图1所示。2.5. 2% agarose gel electrophoresis was performed at 180 V, 180 mA, 100 W for 30 minutes. The results are shown in FIG1 .
3、Tn5酶片段化建库:3. Tn5 enzyme fragmentation library construction:
3.1、Tn5酶片段化:(Vazyme TD501试剂盒)3.1. Tn5 enzyme fragmentation: (Vazyme TD501 kit)
(1)向纯化的线粒体中加入12.4ul 2xTD+0.5ul Tn5,混匀;(1) Add 12.4ul 2xTD + 0.5ul Tn5 to the purified mitochondria and mix well;
(2)金属浴37度,震荡20-40min;(2) Metal bath at 37°C, shake for 20-40 min;
(3)使用Zymo D4014试剂盒进行纯化;(3) Purification using the Zymo D4014 kit;
(4)PCR加接头引物(Vazyme TD501试剂盒):(4) PCR plus adapter primer (Vazyme TD501 kit):
PCR条件:98℃预变性30秒;98℃变性10秒,63℃退火30秒,72℃延伸1分钟,循环16-18次;4℃保持PCR conditions: 98℃ pre-denaturation for 30 seconds; 98℃ denaturation for 10 seconds, 63℃ annealing for 30 seconds, 72℃ extension for 1 minute, 16-18 cycles; 4℃ hold
3.2、吸取1uL进行2%琼脂糖凝胶电泳跑胶,结果如图2所示;3.2. Take 1uL and run it on 2% agarose gel electrophoresis. The result is shown in Figure 2.
3.3、双轮磁珠分选:3.3. Double-wheel magnetic bead sorting:
1):吸取0.5×磁珠至PCR产物中,涡旋振荡混匀,瞬时离心后室温静置5min;1) Pipette 0.5× magnetic beads into the PCR product, vortex to mix, centrifuge briefly, and let stand at room temperature for 5 minutes;
2):将EP管置于磁力架上,静置5min至磁珠完全吸附;2): Place the EP tube on the magnetic rack and let it stand for 5 minutes until the magnetic beads are completely adsorbed;
3):保持EP管置于磁力架上,小心吸取上清至新的EP管,避免接触到磁珠;3): Keep the EP tube on the magnetic stand and carefully pipette the supernatant into a new EP tube to avoid contact with the magnetic beads;
4):加入0.3×磁珠,涡旋振荡混匀,瞬时离心后室温静置5min;4): Add 0.3× magnetic beads, vortex to mix, centrifuge briefly, and let stand at room temperature for 5 minutes;
5):将EP管置于磁力架上,静置5min至磁珠完全吸附;5): Place the EP tube on the magnetic rack and let it stand for 5 minutes until the magnetic beads are completely adsorbed;
6):保持EP管置于磁力架上,小心吸弃上清;6) Keep the EP tube on the magnetic rack and carefully discard the supernatant;
7):向EP管中加入250ul新鲜配置的80%乙醇,静置3-5min,待悬起的磁珠完全吸附后吸弃乙醇;7) Add 250ul of freshly prepared 80% ethanol to the EP tube, let it stand for 3-5min, and then discard the ethanol after the suspended magnetic beads are completely adsorbed;
8):80%乙醇重复洗涤一次,然后吸净;8): Repeat washing once with 80% ethanol, then aspirate clean;
9):保持EP管置于磁力架上,静置5min至乙醇挥发干净;9) Keep the EP tube on the magnetic rack and let it stand for 5 minutes until the ethanol evaporates completely;
10):向EP管中加入H20,涡旋振荡混匀,室温静置5min;10): Add H 2 0 to the EP tube, vortex and mix, and let stand at room temperature for 5 minutes;
11):将EP管置于磁力架上,静置5min至磁珠完全吸附;11): Place the EP tube on the magnetic rack and let it stand for 5 minutes until the magnetic beads are completely adsorbed;
12):吸取洗脱液至新的EP管中,弃去磁珠;12): Pipette the eluate into a new EP tube and discard the magnetic beads;
3.4、分别吸取2uL进行Qubit浓度测定,然后混样;3.4. Take 2uL of each sample for Qubit concentration determination, and then mix the samples;
4、使用Illumina平台对所建文库进行双端测序,各150bp。然后使用GATK线粒体基因组标准化分析流程,将所得序列与人类线粒体基因组NC_012920数据库进行比对,把所有映射到线粒体基因组的短序列用于下游的变异位点分析。4. Use the Illumina platform to perform double-end sequencing of the constructed library, 150bp each. Then use the GATK mitochondrial genome standardized analysis process to compare the obtained sequence with the human mitochondrial genome NC_012920 database, and use all short sequences mapped to the mitochondrial genome for downstream variant site analysis.
5、结果整理:5. Results summary:
本方法的平均测序深度为35298×。测序结果如表1所示。The average sequencing depth of this method was 35298×. The sequencing results are shown in Table 1.
表1Table 1
实施例2Example 2
针对实施例1同一样本,使用长片段PCR方法对其进行建库并测序。其中,长片段PCR建库方法使用2对引物将线粒体DNA分成两段,引物序列为:For the same sample in Example 1, a long-fragment PCR method was used to construct a library and sequence it. The long-fragment PCR library construction method uses two pairs of primers to divide the mitochondrial DNA into two segments, and the primer sequences are:
F1-For:GCAAATCTTACCCCGCCTG(SEQ ID NO.9);F1-For: GCAAATCTTACCCCGCCTG (SEQ ID NO. 9);
F1-Rev:AATTAGGCTGTGGGTGGTTG(SEQ ID NO.10);F1-Rev: AATTAGGCTGTGGGTGGTTG (SEQ ID NO. 10);
F2-For:GCCATACTAGTCTTTGCCGC(SEQ ID NO.11);F2-For: GCCATACTAGTCTTTGCCGC (SEQ ID NO. 11);
F2-Rev:GGCAGGTCAATTTCACTGG(SEQ ID NO.12);F2-Rev: GGCAGGTCAATTTCACTGG (SEQ ID NO. 12);
长片段PCR方法的平均测序深度为26030×。测序结果如表2所示。The average sequencing depth of the long-fragment PCR method was 26030×. The sequencing results are shown in Table 2.
表2Table 2
本发明方法与长片段PCR方法相比,通过分析文库覆盖度可发现两者均具有较好的文库均一性(见图3)。但对于整个建库流程而言,长片段PCR方法耗时2天,本方法用时6小时,可见本发明方法的效率远远高于长片段法。通过测序结果对比(表1和表2)看出,对于异质性突变比例在10%-100%之间的位点,本发明方法与长片段PCR这两种方法检测到的点及其异质度完全一致;当异质度小于10%,两种方法得到的结果略有差别,但基本一致。Compared with the long-fragment PCR method, the method of the present invention has good library uniformity by analyzing the library coverage (see Figure 3). However, for the entire library construction process, the long-fragment PCR method takes 2 days, and the present method takes 6 hours. It can be seen that the efficiency of the method of the present invention is much higher than that of the long-fragment method. By comparing the sequencing results (Table 1 and Table 2), it can be seen that for sites with heterogeneous mutation ratios between 10% and 100%, the points detected by the method of the present invention and the long-fragment PCR method and their heterogeneity are completely consistent; when the heterogeneity is less than 10%, the results obtained by the two methods are slightly different, but basically consistent.
Claims (4)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202211367152.6A CN115896240B (en) | 2022-11-02 | 2022-11-02 | Method for constructing mitochondrial genome sequencing library |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202211367152.6A CN115896240B (en) | 2022-11-02 | 2022-11-02 | Method for constructing mitochondrial genome sequencing library |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN115896240A CN115896240A (en) | 2023-04-04 |
| CN115896240B true CN115896240B (en) | 2024-07-16 |
Family
ID=86477522
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202211367152.6A Active CN115896240B (en) | 2022-11-02 | 2022-11-02 | Method for constructing mitochondrial genome sequencing library |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN115896240B (en) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2356540A1 (en) * | 2001-08-30 | 2003-02-28 | Emory University | Expressed dna sequences involved in mitochondrial functions |
| CN103602735B (en) * | 2013-11-06 | 2016-03-30 | 复旦大学 | Utilize the method that high-flux sequence Accurate Measurement Mitochondrial DNA high and low frequency suddenlys change |
| CN105907748B (en) * | 2016-05-10 | 2017-10-13 | 广州嘉检医学检测有限公司 | Mitochondrial genome library based on high-throughput sequencing and construction method thereof |
| CN110305945A (en) * | 2019-07-09 | 2019-10-08 | 中国人民解放军第四军医大学 | A mutation detection technology of cell-free mitochondrial DNA based on next-generation sequencing technology |
-
2022
- 2022-11-02 CN CN202211367152.6A patent/CN115896240B/en active Active
Non-Patent Citations (3)
| Title |
|---|
| PCR-Free Enrichment of Mitochondrial DNA from Human Blood and Cell Lines for High Quality Next-Generation DNA Sequencing;Meetha P. Gould等;PLoS ONE;20151021;第10卷(第10期);e0139253 * |
| The efficiency of Nextera XT tagmentation depends on G and C bases in the binding motif leading to uneven coverage in bacterial species with low and neutral GC-content;Bo Segerman等;Front. Microbiol.;20220714;第13卷;1-15 * |
| 一种基于线粒体分离纯化技术的新型线粒体DNA深度测序方法;朱玉青等;临床检验杂志;20230331;第41卷(第3期);161-166 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN115896240A (en) | 2023-04-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN107955835B (en) | Primer pool and detection method for detecting BRCA1/2 gene mutation | |
| CN107541561B (en) | Kit, device and method for improving concentration of fetal free DNA in maternal peripheral blood | |
| CN105624272B (en) | Method and device for constructing nucleic acid sequencing library of predetermined genome region | |
| WO2016049878A1 (en) | Snp profiling-based parentage testing method and application | |
| CN103614482B (en) | Based on the method for high-throughput gene sequencing Non-invasive detection Mitochondrial DNA | |
| WO2018112806A1 (en) | Method for converting linear sequencing library to circular sequencing library | |
| CN108517567B (en) | Adapters, primer sets, kits and library construction methods for cfDNA library construction | |
| CN110878334B (en) | Primers for amplicon sequencing and two-step PCR library construction method | |
| CN105861700A (en) | High throughput test method for neuromuscular disorders | |
| CN105603100A (en) | Amplification primers, kit and method for detecting F8 gene mutation | |
| WO2019114473A1 (en) | Establishment and application of human immortalized b lymphocyte cell line group | |
| CN115612746A (en) | A Targeted Capture Sequencing Chip for Genetic Relationship Identification of Broilers | |
| CN116515955B (en) | Multi-gene targeting typing method | |
| CN109280696B (en) | Method for splitting mixed sample by SNP detection technology | |
| CN116083529B (en) | A method for targeted enrichment of DNA in target regions of the genome and its application | |
| CN108060227A (en) | A kind of amplimer, kit and its detection method for detecting PAH gene mutations | |
| CN115896240B (en) | Method for constructing mitochondrial genome sequencing library | |
| Wei et al. | CRISPR/Cas13a-based single-nucleotide polymorphism detection for reliable determination of ABO blood group genotypes | |
| CN110777154A (en) | Mutant gene for drug resistance detection of Mycobacterium tuberculosis, and its detection method and kit | |
| CN114015749A (en) | Construction method of mitochondrial genome sequencing library based on high-throughput sequencing and amplification primer | |
| CN110734974A (en) | A cancer chemotherapy drug SNP site combination and detection primers | |
| CN117625808A (en) | Primer group and kit for detecting RHD gene zygosity type | |
| CN114634970A (en) | Panel detection method for hereditary Alzheimer's disease causative gene | |
| CN115807069A (en) | Capture probe kit for glioma diagnosis and application thereof | |
| CN114525328A (en) | Kit for detecting HLA-I/II gene expression typing and expression quantity at single cell level and use method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |